INACTIVATED VACCINE AGAINST HENS' HYDROPERICARDITIS SYNDROME
FIELD: veterinary virology and biotechnology. SUBSTANCE: the suggested vaccine contains an antigenic material as 10- 20%-virus-containing suspension from KR95N114 strain of HHPS virus, dimer ethylenimine inactivant (DEI) and adjuvants - aluminum oxide hydrate and saponin at an efficient ratio. The s...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | FIELD: veterinary virology and biotechnology. SUBSTANCE: the suggested vaccine contains an antigenic material as 10- 20%-virus-containing suspension from KR95N114 strain of HHPS virus, dimer ethylenimine inactivant (DEI) and adjuvants - aluminum oxide hydrate and saponin at an efficient ratio. The strain is depoted in the collection of microorganisms in VGNKI under registration number of KR95N114-DEP. It is reproduced on 5-50-d-aged chickens at the titer of infectious activity of 3.25-5.0 lgLD50/02 cm3. Vaccine represents a rose-brown-colored liquid with a friable residue of a sorbent easily divided into a homogenic suspension at shaking. Vaccine is nonreactogenic, immunogenic and safe for vaccinated poultry. EFFECT: higher efficiency. 10 cl, 6 ex, 5 tbl |
---|